$15.95
6.18% day before yesterday
Nasdaq, Jan 02, 10:06 pm CET
ISIN
SG9999014716
Symbol
WVE

Wave Life Sciences Ltd. Stock price

$15.95
+8.96 128.18% 1M
+9.20 136.30% 6M
-1.05 6.18% YTD
+2.64 19.79% 1Y
+8.95 127.86% 3Y
+7.66 92.40% 5Y
+0.88 5.84% 10Y
-0.05 0.31% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-1.05 6.18%
ISIN
SG9999014716
Symbol
WVE
Industry

Key metrics

Basic
Market capitalization
$2.9b
Enterprise Value
$2.7b
Net debt
positive
Cash
$196.2m
Shares outstanding
160.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
26.7 | 67.9
EV/Sales
24.9 | 63.3
EV/FCF
negative
P/B
22.1
Financial Health
Equity Ratio
61.7%
Return on Equity
-44.7%
ROCE
-87.7%
ROIC
838.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$109.2m | $43.0m
EBITDA
$-132.5m | $-203.7m
EBIT
$-136.0m | $-208.5m
Net Income
$-122.0m | $-192.2m
Free Cash Flow
$-198.8m
Growth (TTM | estimate)
Revenue
103.8% | -60.3%
EBITDA
10.5% | -92.0%
EBIT
10.6% | -89.6%
Net Income
14.6% | -98.1%
Free Cash Flow
-40.6%
Margin (TTM | estimate)
Gross
-
EBITDA
-121.3% | -473.5%
EBIT
-124.5%
Net
-111.7% | -446.8%
Free Cash Flow
-182.0%
More
EPS
$-0.7
FCF per Share
$-1.2
Short interest
10.2%
Employees
288
Rev per Employee
$380.0k
Show more

Is Wave Life Sciences Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Wave Life Sciences Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Wave Life Sciences Ltd. forecast:

18x Buy
90%
2x Hold
10%

Analyst Opinions

20 Analysts have issued a Wave Life Sciences Ltd. forecast:

Buy
90%
Hold
10%

Financial data from Wave Life Sciences Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
109 109
104% 104%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 70 70
25% 25%
64%
- Research and Development Expense 175 175
17% 17%
160%
-132 -132
11% 11%
-121%
- Depreciation and Amortization 3.51 3.51
14% 14%
3%
EBIT (Operating Income) EBIT -136 -136
11% 11%
-125%
Net Profit -122 -122
15% 15%
-112%

In millions USD.

Don't miss a Thing! We will send you all news about Wave Life Sciences Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Wave Life Sciences Ltd. Stock News

Neutral
24/7 Wall Street
17 days ago
In the past week or so, secondary offerings from biotechs Immunovant Inc. (NASDAQ: IMVT), Kymera Therapeutics Inc.
Positive
Forbes
19 days ago
A surge of 147% in a single session is an unusual occurrence in biotech — and nearly unprecedented for a company that has spent years trading discreetly under the radar. However, that is precisely what transpired with Wave Life Sciences (NASDAQ:WVE), the RNA-focused drug developer that astonished Wall Street with data so unexpectedly robust that it reshaped the company's future in just a few ho...
Positive
MarketBeat
24 days ago
The golden cross is a highly accurate and bullish technical signal that investors can use to find stocks that can make good momentum trades. A golden cross pattern forms when a stock's 50-day moving average crosses above its 200-day moving average.
More Wave Life Sciences Ltd. News

Company Profile

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Head office Singapore
CEO Paul Bolno
Employees 288
Founded 2012
Website www.wavelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today